ÂÜÀòÂÒÂ×

The Leadership Team at Genomind is responsible for guiding the company's strategic direction in personalized neuropsychiatry. Composed of key executives, including the Chief Scientific Officer and Chief Medical Officer, this team collaborates on research initiatives, clinical development, and medical affairs to advance innovative treatments and improve patient outcomes in mental health. They play a critical role in fostering partnerships, ensuring regulatory compliance, and driving scientific excellence within the organization.